CanRIO is a network of Canadian rheumatologists and researchers with expertise in the management of the rheumatic complications of cancer immunotherapy. These include the development of new rheumatic conditions which develop during or after treatment with immunotherapy, termed rheumatic immune related adverse events (Rh ir-AE) and on the management of patients with rheumatic disease who are being treated or being considered for treatment with immunotherapy.
Site content continues to be developed and will be updated on a continuous basis as emerging evidence becomes available. Please check back frequently!
To improve the care of cancer patients across Canada receiving immunotherapy, who develop rheumatic complications or have pre-existing autoimmune conditions, through collaboration, education and research.